Board Meeting Intimation for Consideration Of Financial Result For The Quarter And Nine Months Ended 31St December, 2025

Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve Pursuant to Regulations 29 and 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Thursday, February 12, 2026, at the Registered Office of the Company, inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results along with the Limited Review Report for the quarter and nine months ended December 31, 2025, and any other business with the permission of the Chair.In terms of Regulation 46 of the SEBI LODR Regulations, the intimation shall be available on the Company's website at https://vivanzabiosciences.com/announcement/.Further, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct, the trading window has been closed and shall remain closed till 48 hours after the declaration of the aforesaid financial results.

View Attachment